In 2022. Sino-American Huadong Pharmaceutical Co., Ltd. was established in 1993, which is a comprehensive pharmaceutical enterprise integrating medicine, western medicine, biotechnology, raw material medicine products and their preparations. As of June 4, 2022, the company released the flower of life Fund, which was established in 2022, focusing on the special group of organ transplant recipients. It rushed to COVID-19 before all kinds of public health and safety emergencies occurred.